Author: Dhir A. Kulkarni S.
Publisher: Springer Publishing Company
ISSN: 1568-5608
Source: Inflammopharmacology, Vol.14, Iss.5-6, 2006-12, pp. : 222-225
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
By Borowicz K.K. Luszczki J. Swiader M. Kleinrok Z. Czuczwar S.J.
European Neuropsychopharmacology, Vol. 14, Iss. 1, 2004-01 ,pp. :
Pharmacokinetics of Rofecoxib: A Specific Cyclo-Oxygenase-2 Inhibitor
By Davies N.M.
Clinical Pharmacokinetics, Vol. 42, Iss. 6, 2003-01 ,pp. :
By Ohno Ryoko Miyazawa Tohru Hayashi Yujiro Kanatsu Kenji Tanaka Akiko Takeuchi Koji
Inflammopharmacology, Vol. 10, Iss. 4-6, 2002-12 ,pp. :
By Martin A.R. Villegas I. La Casa C. Alarcon de la Lastra C.
European Journal of Pharmacology, Vol. 481, Iss. 2, 2003-11 ,pp. :